ELECTROMED INC (ELMD) Stock Fundamental Analysis

NYSEARCA:ELMD • US2854091087

23.92 USD
+0.77 (+3.33%)
At close: Feb 25, 2026
24 USD
+0.08 (+0.33%)
After Hours: 2/25/2026, 8:07:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Overall ELMD gets a fundamental rating of 7 out of 10. We evaluated ELMD against 185 industry peers in the Health Care Equipment & Supplies industry. ELMD gets an excellent profitability rating and is at the same time showing great financial health properties. ELMD is not valued too expensively and it also shows a decent growth rate. These ratings could make ELMD a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • ELMD had positive earnings in the past year.
  • ELMD had a positive operating cash flow in the past year.
  • Each year in the past 5 years ELMD has been profitable.
  • Of the past 5 years ELMD 4 years had a positive operating cash flow.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • ELMD's Return On Assets of 15.29% is amongst the best of the industry. ELMD outperforms 96.76% of its industry peers.
  • With an excellent Return On Equity value of 18.32%, ELMD belongs to the best of the industry, outperforming 94.05% of the companies in the same industry.
  • ELMD has a better Return On Invested Capital (17.31%) than 96.76% of its industry peers.
  • ELMD had an Average Return On Invested Capital over the past 3 years of 11.76%. This is above the industry average of 8.75%.
  • The last Return On Invested Capital (17.31%) for ELMD is above the 3 year average (11.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 15.29%
ROE 18.32%
ROIC 17.31%
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ELMD has a Profit Margin of 12.38%. This is amongst the best in the industry. ELMD outperforms 87.57% of its industry peers.
  • In the last couple of years the Profit Margin of ELMD has declined.
  • ELMD has a Operating Margin of 16.01%. This is amongst the best in the industry. ELMD outperforms 84.86% of its industry peers.
  • In the last couple of years the Operating Margin of ELMD has grown nicely.
  • ELMD has a better Gross Margin (78.04%) than 90.27% of its industry peers.
  • In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
Industry RankSector Rank
OM 16.01%
PM (TTM) 12.38%
GM 78.04%
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELMD is creating some value.
  • ELMD has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ELMD has been reduced compared to 5 years ago.
  • ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • ELMD has an Altman-Z score of 16.77. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ELMD (16.77) is better than 94.05% of its industry peers.
  • ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.77
ROIC/WACC1.75
WACC9.88%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • ELMD has a Current Ratio of 5.09. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 5.09, ELMD is doing good in the industry, outperforming 77.84% of the companies in the same industry.
  • A Quick Ratio of 4.66 indicates that ELMD has no problem at all paying its short term obligations.
  • The Quick ratio of ELMD (4.66) is better than 80.54% of its industry peers.
Industry RankSector Rank
Current Ratio 5.09
Quick Ratio 4.66
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.33%, which is quite impressive.
  • The Earnings Per Share has been growing by 17.82% on average over the past years. This is quite good.
  • The Revenue has grown by 16.97% in the past year. This is quite good.
  • Measured over the past years, ELMD shows a quite strong growth in Revenue. The Revenue has been growing by 14.53% on average per year.
EPS 1Y (TTM)37.33%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%45.45%
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%16.25%

3.2 Future

  • Based on estimates for the next years, ELMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.13% on average per year.
  • The Revenue is expected to grow by 9.48% on average over the next years. This is quite good.
EPS Next Y28.75%
EPS Next 2Y26.7%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue Next Year14.79%
Revenue Next 2Y12.98%
Revenue Next 3Y9.48%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.22, ELMD is valued on the expensive side.
  • ELMD's Price/Earnings ratio is rather cheap when compared to the industry. ELMD is cheaper than 80.54% of the companies in the same industry.
  • ELMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 17.74, ELMD is valued on the expensive side.
  • 84.32% of the companies in the same industry are more expensive than ELMD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, ELMD is valued a bit cheaper.
Industry RankSector Rank
PE 23.22
Fwd PE 17.74
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ELMD is valued cheaply inside the industry as 81.62% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELMD indicates a rather cheap valuation: ELMD is cheaper than 88.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.83
EV/EBITDA 15.69
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • ELMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.81
PEG (5Y)1.3
EPS Next 2Y26.7%
EPS Next 3Y10.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ELMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELECTROMED INC

NYSEARCA:ELMD (2/25/2026, 8:07:04 PM)

After market: 24 +0.08 (+0.33%)

23.92

+0.77 (+3.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-11
Inst Owners51.92%
Inst Owner Change14.98%
Ins Owners8.11%
Ins Owner Change3.36%
Market Cap199.49M
Revenue(TTM)64.00M
Net Income(TTM)8.20M
Analysts82
Price Target36.72 (53.51%)
Short Float %2.65%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.34%
Min EPS beat(2)13.12%
Max EPS beat(2)19.56%
EPS beat(4)4
Avg EPS beat(4)13.86%
Min EPS beat(4)2.94%
Max EPS beat(4)19.83%
EPS beat(8)8
Avg EPS beat(8)79.11%
EPS beat(12)10
Avg EPS beat(12)64.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-2.61%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)0.42%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)4.16%
Revenue beat(8)4
Avg Revenue beat(8)0.57%
Revenue beat(12)6
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.69%
EPS NY rev (1m)0%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 23.22
Fwd PE 17.74
P/S 3.01
P/FCF 22.83
P/OCF 21.56
P/B 4.46
P/tB 4.6
EV/EBITDA 15.69
EPS(TTM)1.03
EY4.31%
EPS(NY)1.35
Fwd EY5.64%
FCF(TTM)1.05
FCFY4.38%
OCF(TTM)1.11
OCFY4.64%
SpS7.94
BVpS5.37
TBVpS5.2
PEG (NY)0.81
PEG (5Y)1.3
Graham Number11.15
Profitability
Industry RankSector Rank
ROA 15.29%
ROE 18.32%
ROCE 23.64%
ROIC 17.31%
ROICexc 25.26%
ROICexgc 26.48%
OM 16.01%
PM (TTM) 12.38%
GM 78.04%
FCFM 13.2%
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
ROICexc(3y)17.46%
ROICexc(5y)14.38%
ROICexgc(3y)18.08%
ROICexgc(5y)14.87%
ROCE(3y)16.06%
ROCE(5y)13.3%
ROICexgc growth 3Y46.82%
ROICexgc growth 5Y11%
ROICexc growth 3Y45.6%
ROICexc growth 5Y10.61%
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
F-Score8
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.53%
Cap/Sales 0.78%
Interest Coverage 250
Cash Conversion 78.32%
Profit Quality 106.57%
Current Ratio 5.09
Quick Ratio 4.66
Altman-Z 16.77
F-Score8
WACC9.88%
ROIC/WACC1.75
Cap/Depr(3y)117.67%
Cap/Depr(5y)133.86%
Cap/Sales(3y)1.59%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.33%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%45.45%
EPS Next Y28.75%
EPS Next 2Y26.7%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%16.25%
Revenue Next Year14.79%
Revenue Next 2Y12.98%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
EBIT growth 1Y26.58%
EBIT growth 3Y49.21%
EBIT growth 5Y18.61%
EBIT Next Year79.36%
EBIT Next 3Y12.1%
EBIT Next 5YN/A
FCF growth 1Y645.56%
FCF growth 3YN/A
FCF growth 5Y28.06%
OCF growth 1Y234.65%
OCF growth 3YN/A
OCF growth 5Y22.11%

ELECTROMED INC / ELMD FAQ

What is the ChartMill fundamental rating of ELECTROMED INC (ELMD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ELMD.


What is the valuation status for ELMD stock?

ChartMill assigns a valuation rating of 6 / 10 to ELECTROMED INC (ELMD). This can be considered as Fairly Valued.


How profitable is ELECTROMED INC (ELMD) stock?

ELECTROMED INC (ELMD) has a profitability rating of 8 / 10.


What is the financial health of ELECTROMED INC (ELMD) stock?

The financial health rating of ELECTROMED INC (ELMD) is 9 / 10.


What is the expected EPS growth for ELECTROMED INC (ELMD) stock?

The Earnings per Share (EPS) of ELECTROMED INC (ELMD) is expected to grow by 28.75% in the next year.